ArticlePloS one2021

Protocol: Benefits and harms of remdesivir for COVID-19 in adults: A systematic review with meta-analysis.

Asger Sand Paludan-Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.